Skip to main content
The Markets by Proactive
Go to Proactive Australia

Archive

MGC Pharmaceuticals: analyst reviews prospects after recent results and funding

MGC Pharmaceuticals: analyst reviews prospects after recent results and funding

Proactive Research analyst John Savin presents his analysis on MGC Pharmaceuticals.

The core marketed products are a food supplement, ArtemiC, to help overcome COVID-19 infection and medicinal cannabis products sold in Australia, UK and Ireland.

He also talk about the new medical ZAM app: a real-time data collection smartphone app with proprietary artificial intelligence (AI) algorithms.

Click here to read the report